NCT05130983 - Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions

Crohn DiseaseInflammatory Bowel Diseases

Interventions

BIOLOGICAL

ExoFlo

Intravenous administration of bone marrow mesenchymal stem cell derived extracellular vesicles

Trial Locations (2)

Direct Biologics Investigational Site, New York

Direct Biologics Investigational Site, Los Angeles